chr16-85921636-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002163.4(IRF8):c.*354C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.219 in 279,678 control chromosomes in the GnomAD database, including 6,989 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.23 ( 3935 hom., cov: 33)
Exomes 𝑓: 0.21 ( 3054 hom. )
Consequence
IRF8
NM_002163.4 3_prime_UTR
NM_002163.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.506
Publications
20 publications found
Genes affected
IRF8 (HGNC:5358): (interferon regulatory factor 8) Interferon consensus sequence-binding protein (ICSBP) is a transcription factor of the interferon (IFN) regulatory factor (IRF) family. Proteins of this family are composed of a conserved DNA-binding domain in the N-terminal region and a divergent C-terminal region that serves as the regulatory domain. The IRF family proteins bind to the IFN-stimulated response element (ISRE) and regulate expression of genes stimulated by type I IFNs, namely IFN-alpha and IFN-beta. IRF family proteins also control expression of IFN-alpha and IFN-beta-regulated genes that are induced by viral infection. [provided by RefSeq, Jul 2008]
IRF8 Gene-Disease associations (from GenCC):
- Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiencyInheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, Illumina
- immunodeficiency 32BInheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 16-85921636-C-T is Benign according to our data. Variant chr16-85921636-C-T is described in ClinVar as Benign. ClinVar VariationId is 1168174.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.234 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| IRF8 | NM_002163.4 | c.*354C>T | 3_prime_UTR_variant | Exon 9 of 9 | ENST00000268638.10 | NP_002154.1 | ||
| IRF8 | NM_001363907.1 | c.*354C>T | 3_prime_UTR_variant | Exon 9 of 9 | NP_001350836.1 | |||
| IRF8 | NM_001363908.1 | c.*354C>T | 3_prime_UTR_variant | Exon 7 of 7 | NP_001350837.1 | |||
| IRF8 | XM_047434052.1 | c.*354C>T | 3_prime_UTR_variant | Exon 10 of 10 | XP_047290008.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.225 AC: 34230AN: 152012Hom.: 3929 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
34230
AN:
152012
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.212 AC: 27001AN: 127548Hom.: 3054 Cov.: 0 AF XY: 0.205 AC XY: 13747AN XY: 67134 show subpopulations
GnomAD4 exome
AF:
AC:
27001
AN:
127548
Hom.:
Cov.:
0
AF XY:
AC XY:
13747
AN XY:
67134
show subpopulations
African (AFR)
AF:
AC:
892
AN:
3790
American (AMR)
AF:
AC:
863
AN:
4762
Ashkenazi Jewish (ASJ)
AF:
AC:
663
AN:
3500
East Asian (EAS)
AF:
AC:
1244
AN:
5900
South Asian (SAS)
AF:
AC:
2673
AN:
19334
European-Finnish (FIN)
AF:
AC:
1899
AN:
6218
Middle Eastern (MID)
AF:
AC:
67
AN:
512
European-Non Finnish (NFE)
AF:
AC:
17141
AN:
76606
Other (OTH)
AF:
AC:
1559
AN:
6926
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1017
2034
3051
4068
5085
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
146
292
438
584
730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.225 AC: 34268AN: 152130Hom.: 3935 Cov.: 33 AF XY: 0.226 AC XY: 16770AN XY: 74366 show subpopulations
GnomAD4 genome
AF:
AC:
34268
AN:
152130
Hom.:
Cov.:
33
AF XY:
AC XY:
16770
AN XY:
74366
show subpopulations
African (AFR)
AF:
AC:
9875
AN:
41500
American (AMR)
AF:
AC:
2742
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
655
AN:
3468
East Asian (EAS)
AF:
AC:
1020
AN:
5184
South Asian (SAS)
AF:
AC:
607
AN:
4830
European-Finnish (FIN)
AF:
AC:
3225
AN:
10552
Middle Eastern (MID)
AF:
AC:
43
AN:
294
European-Non Finnish (NFE)
AF:
AC:
15459
AN:
67984
Other (OTH)
AF:
AC:
464
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1427
2855
4282
5710
7137
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
366
732
1098
1464
1830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
612
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency;C4751209:Immunodeficiency 32B Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.